Daw-Tsun Shih

Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand.

G. Nabozny, Ljiljana Žuvela-Jelaska, D. Kuzmich, 2005, Bioorganic & medicinal chemistry letters.

Exploration of cathepsin S inhibitors characterized by a triazole P1-P2 amide replacement.

E. Hickey, N. Moss, Yancey D. Ward, 2012, Bioorganic & medicinal chemistry letters.

Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: optimization of drug-like properties and target independent parameters.

Sabine Löbbe, M. Gemkow, Mita Patel, 2011, Bioorganic & medicinal chemistry letters.

1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stability.

Daniel R. Albaugh, P. Cirillo, Sabine Löbbe, 2011, Bioorganic & medicinal chemistry letters.

Morpholine containing CB2 selective agonists.

Sabine Löbbe, A. Ebneth, M. Gemkow, 2009, Bioorganic & medicinal chemistry letters.

Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity.

B. Dymock, Sabine Löbbe, M. Brewer, 2008, Bioorganic & medicinal chemistry letters.

Development of a homogeneous binding assay for histamine receptors.

K. Crane, Daw-Tsun Shih, Kathy Crane, 2004, Analytical biochemistry.

A small‐molecule antagonist of LFA‐1 blocks a conformational change important for LFA‐1 function

N. Hogg, J. Woska, T. Kishimoto, 2001, Journal of leukocyte biology.